PT-141
10 mg (lyophilized)
Purity:
≥99% (HPLC)
Cap colour is for illustration purposes only
PT-141
10 mg (lyophilized)
+ $25 flat-rate shipping · free at $300+ · Interac e-Transfer ·
Volume pricing
About this compound
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II. It has been studied in preclinical research for its activation of MC3R and MC4R pathways in the central nervous system.
Storage and handling
Store at -20°C lyophilized, away from moisture and UV light. Keep vials sealed until use. Stable for 2+ years in a non-frost-free freezer.
Preclinical research references
Provided for informational context only. All cited studies involve preclinical or in vitro models. Results do not predict human safety or efficacy. These references do not constitute medical claims.
- Rodent models demonstrated dose-dependent behavioral responses associated with MC4R activation in hypothalamic tissue (Pfaus et al., 2004)
- Animal studies observed selective melanocortin receptor binding without significant cardiovascular effects at research doses
- Preclinical pharmacokinetic research showed favorable CNS penetration and receptor affinity profiles compared to linear melanocortin analogues
Shipping & returns
1–5 business days (5–7 for BC, NL and remote areas), Canada-wide tracked courier, double tamper-proof packaging.
All sales final. Damaged or incorrect orders must be reported within 24 hours with photos.
Every batch independently tested for purity. COA on file and available before purchase.
FAQ — PT-141
For research use only. Not for human or veterinary administration.